Management of aneurysmal subarachnoid hemorrhage

被引:100
|
作者
Diringer, Michael N. [1 ]
机构
[1] Washington Univ, Sch Med, St Louis, MO 63130 USA
关键词
aneurysm; subarachnoid hemorrhage; vasospasm; hypertension; treatment; endovascular; CEREBRAL-BLOOD-FLOW; RUPTURED INTRACRANIAL ANEURYSMS; TRANSCRANIAL DOPPLER SONOGRAPHY; COMPUTERIZED-TOMOGRAPHY ANGIOGRAPHY; RISK-FACTORS; ENDOVASCULAR COILING; HYPERVOLEMIC THERAPY; ELECTROCARDIOGRAPHIC CHANGES; INTRAARTERIAL PAPAVERINE; ANTIFIBRINOLYTIC THERAPY;
D O I
10.1097/CCM.0b013e318195865a
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Acute aneurysmal subarachnoid hemorrhage (SAH) is a complex multifaceted disorder that plays out over days to weeks. Many patients with SAH are seriously ill and require a prolonged intensive care unit stay. Cardiopulmonary complications are common. The management of patents with SAH focuses on the anticipation, prevention, and management of these secondary complications. Data Sources: Source data were obtained from a PubMed search of the medical literature. Data Synthesis and Conclusion: The rupture of an intracranial aneurysm is a sudden devastating event with immediate neurologic and cardiac consequences that require stabilization to allow for early diagnostic angiography. Early complications include rebleeding, hydrocephalus, and seizures. Early repair of the an-eurysm (within 1-3 days) should take place by surgical or endo-vascular means. During the first 1-2 weeks after hemorrhage, patients are at risk of delayed ischemic deficits due to vasospasm, autoregulatory failure, and intravascular volume contraction. Delayed ischemia is treated with combinations of volume expansion, induced hypertension, augmentation of cardiac output, angioplasty, and intra-arterial vasodilators. SAH is a complex disease with a prolonged course that can be particularly challenging and rewarding to the intensivist. (Crit Care Med 2009; 37: 432-440)
引用
收藏
页码:432 / 440
页数:9
相关论文
共 50 条
  • [1] MANAGEMENT OF ANEURYSMAL SUBARACHNOID HEMORRHAGE
    MILLER, J
    DIRINGER, M
    [J]. NEUROLOGIC CLINICS, 1995, 13 (03) : 451 - 478
  • [2] Controversies in the management of aneurysmal subarachnoid hemorrhage
    Naval, NS
    Stevens, RD
    Mirski, MA
    Bhardwaj, A
    [J]. CRITICAL CARE MEDICINE, 2006, 34 (02) : 511 - 524
  • [3] Pregabalin in the Management of Aneurysmal Subarachnoid Hemorrhage
    Apostolakis, Sotirios
    [J]. JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2019, 10 (03) : 444 - 445
  • [4] CURRENT MANAGEMENT OF ANEURYSMAL SUBARACHNOID HEMORRHAGE
    SYMON, L
    [J]. BAILLIERES CLINICAL ANAESTHESIOLOGY, 1987, 1 (02): : 295 - 315
  • [5] Surgical Management of Aneurysmal Subarachnoid Hemorrhage
    Colby, Geoffrey P.
    Coon, Alexander L.
    Tamargo, Rafael J.
    [J]. NEUROSURGERY CLINICS OF NORTH AMERICA, 2010, 21 (02) : 247 - +
  • [6] Perioperative Management of Aneurysmal Subarachnoid Hemorrhage
    Sharma, Deepak
    [J]. ANESTHESIOLOGY, 2020, 133 (06) : 1283 - 1305
  • [7] Modern Management of Aneurysmal Subarachnoid Hemorrhage
    Lanzino, Giuseppe
    D'Urso, Pietro I.
    [J]. WORLD NEUROSURGERY, 2011, 76 (05) : 392 - 393
  • [8] Emergency Medical Management of Aneurysmal Subarachnoid Hemorrhage
    Mervyn D. I. Vergouwen
    Gabriel J. E. Rinkel
    [J]. Neurocritical Care, 2023, 39 : 51 - 58
  • [9] Clinical evaluation and management of aneurysmal subarachnoid hemorrhage
    Lasner, TM
    Raps, EC
    [J]. NEUROIMAGING CLINICS OF NORTH AMERICA, 1997, 7 (04) : 669 - &
  • [10] Emergency Medical Management of Aneurysmal Subarachnoid Hemorrhage
    Vergouwen, Mervyn D. I.
    Rinkel, Gabriel J. E.
    [J]. NEUROCRITICAL CARE, 2023, 39 (01) : 51 - 58